5XR1

Structure of FLN IG21 domain in complex with C-terminal peptide of beta-2

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	300 uM [U-13C; U-15N] FLN IG21 domain	90% H2O/10% D2O	150 mM	6.2	1 atm	298	Bruker AVANCE III 600
2	3D CBCA(CO)NH	300 uM [U-13C; U-15N] FLN IG21 domain	90% H2O/10% D2O	150 mM	6.2	1 atm	298	Bruker AVANCE III 600
3	3D HNCACB	300 uM [U-13C; U-15N] FLN IG21 domain	90% H2O/10% D2O	150 mM	6.2	1 atm	298	Bruker AVANCE III 600
4	3D 1H-15N NOESY	300 uM [U-13C; U-15N] FLN IG21 domain	90% H2O/10% D2O	150 mM	6.2	1 atm	298	Bruker AVANCE III 600
5	3D 1H-13C NOESY	300 uM [U-13C; U-15N] FLN IG21 domain	90% H2O/10% D2O	150 mM	6.2	1 atm	298	Bruker AVANCE III 600
6	3D 1H-15N TOCSY	300 uM [U-13C; U-15N] FLN IG21 domain	90% H2O/10% D2O	150 mM	6.2	1 atm	298	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.